Show simple item record

dc.contributor.authorKumaran, Binoy
dc.contributor.authorWatson, Tim
dc.date.accessioned2018-10-10T01:12:08Z
dc.date.available2018-10-10T01:12:08Z
dc.date.issued2018-07-26
dc.identifier.citationKumaran , B & Watson , T 2018 , ' Treatment using 448 kHz capacitive resistive monopolar radiofrequency improves pain and function in patients with osteoarthritis of the knee joint: A randomised controlled trial ' , Physiotherapy . https://doi.org/10.1016/j.physio.2018.07.004
dc.identifier.issn0031-9406
dc.identifier.otherPURE: 15083076
dc.identifier.otherPURE UUID: 78a137d7-4842-49bd-9439-ba1fc424d75f
dc.identifier.otherScopus: 85054027180
dc.identifier.urihttp://hdl.handle.net/2299/20698
dc.description.abstractObjective: This study investigated whether capacitive resistive monopolar radiofrequency (CRMRF)-based treatment improves pain and function among patients with osteoarthritis of the knee. Design and setting: Three-group randomised controlled trial with concealed allocation, participant blinding and intention-to-treat analysis. Forty-five patients diagnosed with osteoarthritis, from the waiting list for physiotherapy at a local hospital were enrolled. Intervention: Participants in the active and sham groups received eight sessions of CRMRF and sham-CRMRF respectively over four weeks, along with standard care. The control group received standard care only. Assessment: Pain and function were measured at four time points: week zero (baseline), week four (post intervention), week eight and week 16 (two follow-ups) using visual analogue scale (VAS), Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index, timed up and go (TUG) test and knee range of motion (ROM). Results: For pain (VAS), there were clinically significant changes in the active group at post treatment compared to sham (Mean difference: 0.79 (95% CI: 0.29 to 1.3), effect size: 1.3) and control (Mean difference: 0.82 (95% CI: 0.32 to 1.3), effect size: 1.5), and at one-month follow-up compared to control (Mean difference: 0.68 (95% CI: 0.10 to 1.3), effect size: 1.1). For function (WOMAC), there was clinically significant change in the active group at post treatment compared to control (Mean difference: 1.3 (95% CI: 0.02 to 2.6), effect size: 0.94), but not compared to sham. No meaningful differences were noted for TUG or knee ROM. No differences were noted at three-month follow-up for any outcomes. Conclusion: CRMRF treatment can improve pain and function in patients with knee osteoarthritis in the short term. Trial registration: NIHR-CRN study ID: 20264.en
dc.language.isoeng
dc.relation.ispartofPhysiotherapy
dc.rightsEmbargoed
dc.subjectElectrophysical agents
dc.subjectFunctional quality of life
dc.subjectJoint pain
dc.subjectOsteoarthritis of knee
dc.subjectRadiofrequency treatment
dc.subjectPhysical Therapy, Sports Therapy and Rehabilitation
dc.titleTreatment using 448 kHz capacitive resistive monopolar radiofrequency improves pain and function in patients with osteoarthritis of the knee joint: A randomised controlled trialen
dc.contributor.institutionSchool of Health and Social Work
dc.contributor.institutionDepartment of Allied Health Professions and Midwifery
dc.contributor.institutionDepartment of Allied Health Professions, Midwifery and Social Work
dc.description.statusPeer reviewed
dc.date.embargoedUntil2019-07-26
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85054027180&partnerID=8YFLogxK
dc.relation.schoolSchool of Health and Social Work
dc.description.versiontypeFinal Accepted Version
dcterms.dateAccepted2018-07-26
rioxxterms.versionAM
rioxxterms.versionofrecordhttps://doi.org/10.1016/j.physio.2018.07.004
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
rioxxterms.licenseref.startdate2019-07-26
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue
herts.date.embargo2019-07-26
herts.rights.accesstypeEmbargoed


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record